RESUMEN
Short-term memory (STM), or the ability to hold verbal information in mind for a few seconds, is known to rely on the integrity of a frontoparietal network of areas. Here, we used functional magnetic resonance imaging to ask whether a similar network is engaged when verbal information is conveyed through a visuospatial language, American Sign Language, rather than speech. Deaf native signers and hearing native English speakers performed a verbal recall task, where they had to first encode a list of letters in memory, maintain it for a few seconds, and finally recall it in the order presented. The frontoparietal network described to mediate STM in speakers was also observed in signers, with its recruitment appearing independent of the modality of the language. This finding supports the view that signed and spoken STM rely on similar mechanisms. However, deaf signers and hearing speakers differentially engaged key structures of the frontoparietal network as the stages of STM unfold. In particular, deaf signers relied to a greater extent than hearing speakers on passive memory storage areas during encoding and maintenance, but on executive process areas during recall. This work opens new avenues for understanding similarities and differences in STM performance in signers and speakers.
Asunto(s)
Encéfalo/fisiología , Imagen por Resonancia Magnética , Memoria a Corto Plazo/fisiología , Recuerdo Mental/fisiología , Lengua de Signos , Estimulación Acústica , Encéfalo/citología , Sordera/fisiopatología , Femenino , Lóbulo Frontal/citología , Lóbulo Frontal/fisiología , Humanos , Masculino , Vías Nerviosas/fisiología , Lóbulo Parietal/citología , Lóbulo Parietal/fisiología , Estimulación Luminosa , Lóbulo Temporal/citología , Lóbulo Temporal/fisiología , Tálamo/citología , Tálamo/fisiología , Aprendizaje Verbal/fisiología , Corteza Visual/citología , Corteza Visual/fisiología , Adulto JovenRESUMEN
Most protein-coding genes in eukaryotes are interrupted by non-coding intervening sequences (introns), which must be precisely removed from primary gene transcripts (pre-mRNAs) before translation of the message into protein. Intron removal by pre-mRNA splicing occurs in the nucleus and is catalysed by complex ribonucleoprotein machines called spliceosomes. These molecular machines consist of several small nuclear RNA molecules and their associated proteins [together termed snRNP (small nuclear ribonucleoprotein) particles], plus multiple accessory factors. Of particular interest are the U2, U5 and U6 snRNPs, which play crucial roles in the catalytic steps of splicing. In the present review, we summarize our current understanding of the role played by the protein components of the U5 snRNP in pre-mRNA splicing, which include some of the largest and most highly conserved nuclear proteins.
Asunto(s)
Ribonucleoproteína Nuclear Pequeña U5/genética , Empalmosomas/metabolismo , Catálisis , Cinética , Modelos Biológicos , Ribonucleoproteína Nuclear Pequeña U5/metabolismo , Ribonucleoproteínas Nucleares Pequeñas/genética , Ribonucleoproteínas Nucleares Pequeñas/metabolismoRESUMEN
We used event-related functional magnetic resonance imaging to identify brain regions involved in syntactic and semantic processing. Healthy adult males read well-formed sentences randomly intermixed with sentences which either contained violations of syntactic structure or were semantically implausible. Reading anomalous sentences, as compared to well-formed sentences, yielded distinct patterns of activation for the two violation types. Syntactic violations elicited significantly greater activation than semantic violations primarily in superior frontal cortex. Semantically incongruent sentences elicited greater activation than syntactic violations in the left hippocampal and parahippocampal gyri, the angular gyri bilaterally, the right middle temporal gyrus, and the left inferior frontal sulcus. These results demonstrate that syntactic and semantic processing result in nonidentical patterns of activation, including greater frontal engagement during syntactic processing and larger increases in temporal and temporo-parietal regions during semantic analyses.
Asunto(s)
Encéfalo/anatomía & histología , Lingüística , Imagen por Resonancia Magnética , Habla/fisiología , Humanos , SemánticaRESUMEN
Nouns may refer to countable objects such as tables, or to mass entities such as rice. The mass/count distinction has been discussed in terms of both semantic and syntactic features encoded in the mental lexicon. Here we show that event-related potentials (ERPs) can reflect the processing of such lexical features, even in the absence of any feature-related violations. We demonstrate that count (vs mass) nouns elicit a frontal negativity which is independent of the N400 marker for conceptual-semantic processing, but resembles anterior negativities related to grammatical processing. This finding suggests that the brain differentiates between count and mass nouns primarily on a syntactic basis.
Asunto(s)
Lenguaje , Procesos Mentales/fisiología , Conducta Verbal/fisiología , Adulto , Electroencefalografía , Potenciales Evocados/fisiología , Humanos , Masculino , SemánticaRESUMEN
By presenting a Poisson process of flashes to observers who hit a button as quickly as possible after each, the authors identified the system involved in simple reaction time (RT). The nonlinear kernels up to 2nd order were measured from the stimulus and response point processes. The 1st-order kernel is analogous to a histogram of simple RTs. The 2nd-order kernel shows complex patterns of nonlinear suppression and facilitation between pairs of flashes. Simple RT measured as the lag of the 1st-order kernel's peak agrees with RT from conventional discrete trial experiments. RTs are shorter and less variable when the flashes are separated by uniform rather than exponential delays, which shows that observers use the stimulus hazard function to become prepared to detect and respond to the flash.
Asunto(s)
Tiempo de Reacción/fisiología , Percepción Visual , Mano , Humanos , Luz , Destreza MotoraRESUMEN
We present here the first insights into the organization of proteins on the RNA in the U5 snRNP of Saccharomyces cerevisiae. Photo-crosslinking with uniformly labeled U5 RNA in snRNPs reconstituted in vitro revealed five contacting proteins, Prp8p, Snu114p, p30, p16, and p10, contact by the three smaller proteins requiring an intact Sm site. Site-specific crosslinking showed that Snu114p contacts the 5' side of internal loop 1, whereas Prp8p interacts with five different regions of the 5' stem-loop, but not with the Sm site or 3' stem-loop. Both internal loops in the 5' domain are essential for Prp8p to associate with the snRNP, but the conserved loop 1 is not, although this is the region to which Prp8p crosslinks most strongly. The extensive contacts between Prp8p and the 5' stem-loop of U5 RNA support the hypothesis that, in spliceosomes, Prp8p stabilizes loop 1-exon interactions. Moreover, data showing that Prp8p contacts the exons even in the absence of loop 1 indicate that Prp8p may be the principal anchoring factor for exons in the spliceosome. This and the close proximity of the spliceosomal translocase, Snu114p, to U5 loop 1 and Prp8p support and extend the proposal that Snu114p mimics U5 loop 1 during a translocation event in the spliceosome.
Asunto(s)
ARN Nuclear Pequeño/química , Ribonucleoproteína Nuclear Pequeña U5/química , Saccharomyces cerevisiae/química , Secuencia de Bases , Cartilla de ADN , Proteínas Fúngicas/química , Mutación , Conformación de Ácido Nucleico , Unión Proteica , Precursores del ARN/química , ARN Nuclear Pequeño/metabolismo , Ribonucleoproteína Nuclear Pequeña U5/metabolismo , Eliminación de Secuencia , Empalmosomas/química , Rayos UltravioletaRESUMEN
We present here the first insights into the organization of proteins on the RNA in the U5 snRNP of Saccharomyces cerevisiae. Photo-crosslinking with uniformly labeled U5 RNA in snRNPs reconstituted in vitro revealed five contacting proteins, Prp8p, Snu114p, p30, p16, and p10, contact by the three smaller proteins requiring an intact Sm site. Site-specific crosslinking showed that Snu114p contacts the 5' side of internal loop 1, whereas Prp8p interacts with five different regions of the 5' stem-loop, but not with the Sm site or 3' stem-loop. Both internal loops in the 5' domain are essential for Prp8p to associate with the snRNP, but the conserved loop 1 is not, although this is the region to which Prp8p crosslinks most strongly. The extensive contacts between Prp8p and the 5' stem-loop of U5 RNA support the hypothesis that, in spliceosomes, Prp8p stabilizes loop 1-exon interactions. Moreover, data showing that Prp8p contacts the exons even in the absence of loop 1 indicate that Prp8p may be the principal anchoring factor for exons in the spliceosome. This and the close proximity of the spliceosomal translocase, Snu114p, to U5 loop 1 and Prp8p support and extend the proposal that Snu114p mimics U5 loop 1 during a translocation event in the spliceosome.
Asunto(s)
ARN Nuclear Pequeño/química , Ribonucleoproteína Nuclear Pequeña U5/química , Proteínas de Saccharomyces cerevisiae , Saccharomyces cerevisiae/química , Reactivos de Enlaces Cruzados , Proteínas Fúngicas/química , Mutación , Conformación de Ácido Nucleico , Unión Proteica , Precursores del ARN/química , ARN Nuclear Pequeño/metabolismo , Ribonucleoproteína Nuclear Pequeña U4-U6 , Ribonucleoproteína Nuclear Pequeña U5/metabolismo , Eliminación de Secuencia , Empalmosomas/química , Rayos UltravioletaRESUMEN
The U5 snRNA loop 1 interacts with the 5' exon before the first step of pre-mRNA splicing and with the 5' and 3' exons following the first step. These U5-exon interactions are proposed to hold the exons in the correct orientation for the second step of splicing. Reconstitution of U5 snRNPs in vitro indicated that U5 loop 1-5' exon interactions are not necessary for the first catalytic step of splicing but are critical for the second step in yeast spliceosomes. We systematically made deletion and insertion mutations in loop 1 then monitored splicing activity and loop-exon interactions by cross-linking. Single nucleotide deletions or insertions in loop 1 permitted both steps of splicing. Larger insertions or deletions allowed the first step but progressively inhibited the second step. Analysis of selected loop 1 insertions and deletions by cross-linking revealed that inhibition of the second catalytic step resulted from misalignment of the 5' and 3' exons. These data indicate that the size of loop 1 is critical for proper alignment of the exons for the second catalytic step of splicing and that the 3' exon is positioned on loop 1 independently of the 5' exon.
Asunto(s)
Precursores del ARN/metabolismo , Empalme del ARN , ARN Nuclear Pequeño/fisiología , Saccharomyces cerevisiae/genética , Catálisis , Exones , Mutagénesis Insercional , Precursores del ARN/genética , ARN Nuclear Pequeño/análisis , ARN Nuclear Pequeño/metabolismo , Eliminación de SecuenciaRESUMEN
The current model for the function of the U5 small nuclear ribonucleoprotein particle (snRNP) in the spliceosome proposes that U5 carries binding sites for the 5' and 3' exons, allowing the spliceosome to 'tether' the 5' exon intermediate produced by the first catalytic step and align it with the 3' exon for the second step. Functional analysis of U5 snRNA in cis-spliceosomes has provided support for this model, and data from nematode and trypanosome splicing systems suggest that U5 or a U5-like snRNA performs a similar role in trans-splicing.
Asunto(s)
Precursores del ARN/metabolismo , Empalme del ARN , Ribonucleoproteína Nuclear Pequeña U5/fisiología , Animales , Catálisis , Exones , Humanos , Intrones , Empalmosomas/fisiologíaRESUMEN
We have developed an in vitro reconstitution system to investigate the role of U5 snRNA in the two catalytic steps of pre-mRNA splicing. The invariant U5 loop 1 is known to interact with exon sequences at the 5' splice site before the first catalytic step. Remarkably, analysis of U5 mutations in vitro reveals that the first transesterification occurs accurately in the absence of the U5 loop. Therefore this sequence is not an essential component of the spliceosomal active site for the first catalytic step. The second catalytic step, although strongly dependent on the presence of a U5 loop to tether the exon 1 splicing intermediate, is surprisingly tolerant of mutations in the invariant sequence.
Asunto(s)
Empalme del ARN , ARN Nuclear Pequeño/metabolismo , Secuencia de Bases , Exones , Datos de Secuencia Molecular , Mutagénesis Sitio-Dirigida , Conformación de Ácido Nucleico , Precursores del ARN/metabolismo , ARN de Hongos/metabolismo , ARN Mensajero/metabolismo , Saccharomyces cerevisiae/genética , Eliminación de Secuencia , Relación Estructura-ActividadRESUMEN
We performed percutaneous liver biopsy in nine children who had received a weekly dose of methotrexate, 10 mg/m2 per week, for at least 3 years to address the concern about subclinical liver toxicity from single, weekly, low-dose methotrexate therapy for juvenile rheumatoid arthritis. No patient had clinical or biochemical evidence of liver injury. All biopsy results were interpreted as normal. These results suggest that the recommendations of the American College of Rheumatology for adults receiving single weekly methotrexate therapy for rheumatoid arthritis can be extended to children.
Asunto(s)
Artritis Juvenil/tratamiento farmacológico , Hígado/efectos de los fármacos , Metotrexato/efectos adversos , Adolescente , Biopsia con Aguja , Niño , Femenino , Humanos , Hígado/patología , Metotrexato/administración & dosificación , Factores de TiempoRESUMEN
Splice site recognition and catalysis of the transesterification reactions in the spliceosome are accompanied by a dynamic series of interactions involving conserved or invariant sequences in the spliceosomal snRNAs. We have used site-specific photoactivated crosslinking in yeast spliceosomes to monitor interactions between snRNAs and exon sequences near the 5' and 3' splice sites. The last nucleotide of the 5' exon can be crosslinked to an invariant loop sequence in U5 SnRNA before and after 5' splice site cleavage. The first nucleotide of the 3' exon can also be crosslinked to the same U5 loop sequence, but this contact is only detectable after the first transesterification. These results are in close agreement with earlier data from mammalian splicing extracts, and they are consistent with a model in which U5 snRNA aligns the 5' and 3' exons for the second transesterification. After the first catalytic step of splicing, the first nucleotide of the 3' exon can also crosslink to nt U23 in U2 snRNA. This is one of a cluster of residues in U2-U6 helix I implicated by mutational analysis in the second catalytic step of splicing. The crosslinking data suggest that these residues in U2-U6 helix I are in close proximity to the scissile phosphodiester bond at the 3' splice site prior to the second transesterification. These results constitute the first biochemical evidence for a direct interaction between the 3' splice site and U2 snRNA.
Asunto(s)
Empalme del ARN , ARN de Hongos , ARN Nuclear Pequeño/genética , Saccharomyces cerevisiae/genética , Empalmosomas/genética , Secuencia de Bases , Biotina/química , Secuencia Conservada , Datos de Secuencia Molecular , Conformación de Ácido Nucleico , Precursores del ARN/análisis , Precursores del ARN/química , ARN Mensajero/síntesis química , ARN Nuclear Pequeño/química , Ribonucleasa H , Ribonucleoproteína Nuclear Pequeña U2/análisis , Ribonucleoproteína Nuclear Pequeña U2/química , Ribonucleoproteína Nuclear Pequeña U5/análisis , Ribonucleoproteína Nuclear Pequeña U5/química , Rayos UltravioletaRESUMEN
Precursor RNAs containing 4-thiouridine at specific sites were used with UV-crosslinking to map the binding sites of the yeast protein splicing factor PRP8. PRP8 protein interacts with a region of at least eight exon nucleotides at the 5' splice site and a minimum of 13 exon nucleotides and part of the polypyrimidine tract in the 3' splice site region. Crosslinking of PRP8 to mutant and duplicated 3' splice sites indicated that the interaction is not sequence specific, nor does it depend on the splice site being functional. Binding of PRP8 to the 5' exon was established before step 1 and to the 3' splice site region after step 1 of splicing. These interactions place PRP8 close to the proposed catalytic core of the spliceosome during both transesterification reactions. To date, this represents the most extensive mapping of the binding site(s) of a splicing factor on the substrate RNA. We propose that the large binding sites of PRP8 stabilize the intrinsically weaker interactions of U5 snRNA with both exons at the splice sites for exon alignment by the U5 snRNP.
Asunto(s)
Proteínas Fúngicas/metabolismo , Empalme del ARN , ARN Nuclear Pequeño/genética , ARN Nuclear Pequeño/metabolismo , Proteínas de Saccharomyces cerevisiae , Secuencia de Bases , Reactivos de Enlaces Cruzados , Cartilla de ADN/genética , Exones , Proteínas Fúngicas/efectos de la radiación , Genes Fúngicos , Intrones , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Precursores del ARN/genética , Precursores del ARN/metabolismo , ARN de Hongos/genética , ARN de Hongos/metabolismo , Ribonucleoproteína Nuclear Pequeña U4-U6 , Ribonucleoproteína Nuclear Pequeña U5 , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/metabolismo , Saccharomyces cerevisiae/efectos de la radiación , Empalmosomas/metabolismoRESUMEN
The removal of introns from precursor messenger RNAs occurs in a large complex, the spliceosome, that contains many proteins and five small nuclear RNAs (snRNAs). The snRNAs interact with the intron-containing substrate RNA and with each other to form a dynamic network of RNA interactions that define the intron and promote splicing. There is evidence that protein splicing factors play important roles in regulating RNA interactions in the spliceosome. PRP8 is a highly conserved protein that is associated in particles with the U5 snRNA and directly binds the substrate RNA in spliceosomes. UV crosslinking has been used to map the binding sites, and shows extensive interaction between PRP8 protein and the 5' exon prior to the first step of splicing and with the 3' splice site region subsequently. It is proposed that PRP8 protein may stabilize fragile interactions between the U5 snRNA and exon sequences at the splice sites, to anchor and align them in the catalytic centre of the spliceosome.
Asunto(s)
Proteínas Fúngicas/metabolismo , Precursores del ARN/metabolismo , Empalme del ARN , Proteínas de Saccharomyces cerevisiae , Saccharomyces cerevisiae/genética , Exones , Humanos , ARN Nuclear Pequeño/metabolismo , Ribonucleoproteína Nuclear Pequeña U4-U6 , Ribonucleoproteína Nuclear Pequeña U5RESUMEN
Rifabutin is a wide spectrum antibiotic particularly active on atypical and rifampicin-resistant mycobacteria. Rifabutin is more potent than rifampicin on Mycobacterium tuberculosis in vitro. Its mode of action is characterized by a high intracellular penetration in treated individuals. Clinical trials have proven the therapeutic value of rifabutin especially in AIDS patients with concomitant MAC. The preclinical safety evaluation of this compound included single and repeated dose toxicity studies of up to one year in rodents and non-rodents, reproduction and carcinogenicity studies and mutagenicity tests. During toxicological studies the most significant finding after repeated administration of rifabutin was the presence of multinucleated hepatocytes (MNH) in rats. This is a species specific finding which did not affect the life span of the hepatocytes. As shown in carcinogenicity studies, there was no tendency to further proliferative changes. Another specific histological feature among the species studied was the presence of a lipofuscin-like brown pigment, which was seen in many organs. This is a common finding with amphipilic compounds, such as rifabutin, which bind lipids and proteins, forming membrane-bound complexes. Even in carcinogenicity studies this change did not constitute a stimulus to cell proliferation and did not cause any secondary changes. In rodents, there was a mild hemolytic anemia at doses higher than 10 mg/kg/day. At doses ranging from 160-200 mg/kg/day rifabutin inhibited the functions of the male gonads in rats. This effect was reflected in a reduction of implantations observed in the fertility studies. Doses of 40 mg/kg/day did not induce any embryotoxic effects or changes in reproductive performance.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Rifabutina/toxicidad , Administración Oral , Animales , Carcinógenos/toxicidad , Femenino , Inyecciones Intravenosas , Masculino , Mutágenos/toxicidad , Reproducción/efectos de los fármacos , Rifabutina/administración & dosificaciónRESUMEN
FCE 22891, a synthetic beta-lactam antibiotic of the penem class, was administered by gavage to Sprague-Dawley rats and cynomolgus monkeys for 26 wk (with and without a 6-wk recovery). Rats received the test material at doses of 0, 200, 500, and 1,250 mg/kg/day, and monkeys were given doses of 0, 100, 200, 400, and 600 mg/kg/day. At the end of the 26-wk treatment period, approximately two-thirds of the animals (both species) were sacrificed, and the remaining animals were held without treatment for a further 6 wk. A treatment-related mortality occurred in female monkeys receiving 600 mg/kg. There was a reduction in body weight gain in the high-dose groups of both species. Male rats were more affected than the females and, conversely, female monkeys were affected more than the males. At higher dose levels, both species exhibited an early, but transient, azotemia and oliguria with an increase in specific gravity and reduced pH. In rats, microscopic examination revealed treatment-related renal cortical tubular degenerative and regenerative changes with associated interstitial inflammation and fibrosis and diffuse urothelial hyperplasia in the urinary bladder. In general, female rats were less severely affected, and in both sexes there was a trend to recovery of most of these effects. In monkeys given 600 mg/kg of the test material, renal cortical tubular degeneration was seen only in those females that died in the first 5 wk of dosing. In other animals at this dose level, the renal lesions were determined to be reversible.
Asunto(s)
Antibacterianos/toxicidad , Corteza Renal/efectos de los fármacos , Riñón/efectos de los fármacos , Lactamas , Vejiga Urinaria/efectos de los fármacos , Orina , Administración Oral , Animales , Antibacterianos/administración & dosificación , Recuento de Células Sanguíneas/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Femenino , Riñón/patología , Corteza Renal/patología , Macaca fascicularis , Masculino , Ratas , Ratas Sprague-Dawley , Vejiga Urinaria/patologíaRESUMEN
Eight of the known chemical substances associated with neoplasia in man are known to target the urinary bladder urothelium. Preneoplastic changes have been identified following exposure to each of these chemicals, and they have also been seen to occur in many species of lab animals. The most important such change is preneoplastic hyperplasia. Adaptive hyperplasia is the first form of hyperplasia to appear. It can be seen both in untreated controls and dosed animals. The distinguishing features are that in treated groups it does not progress with dose or time, and the process is reversible. Reparative hyperplasia involves disruption of homeostasis. Its severity increases with dose and time. It is not seen in controls but it is still reversible during the recovery segment after exposure to a toxic substance. When reparative hyperplasia continues beyond a certain threshold of time and dose, it progresses to preneoplastic hyperplasia, which further progresses with continued stimulation to frank neoplasia. The synthetic beta-lactam penem antibiotic FCE 22891 and its metabolite FCE 22101 caused adaptive urothelial hyperplasia of the urinary bladder only in rats and in no other species. Based on the pharmacokinetic profile of FCE 22891 and FCE 22101, it can be deduced that the morphologic finding of adaptive urothelial hyperplasia is caused by reduction of intravesicular urine pH. This effect has no relevance to therapeutic use in humans. Further, it is important to distinguish adaptive and reparative hyperplasia in preclinical toxicity studies.
Asunto(s)
Antibacterianos/toxicidad , Carbapenémicos/toxicidad , Lactamas , Enfermedades de la Vejiga Urinaria/inducido químicamente , Vejiga Urinaria/patología , beta-Lactamas , Animales , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Femenino , Concentración de Iones de Hidrógeno , Hiperplasia/inducido químicamente , Hiperplasia/patología , Riñón/efectos de los fármacos , Riñón/patología , Masculino , Lesiones Precancerosas/patología , Ratas , Factores de Tiempo , Vejiga Urinaria/efectos de los fármacos , Enfermedades de la Vejiga Urinaria/patología , Neoplasias de la Vejiga Urinaria/patología , Orina/fisiologíaRESUMEN
Information from yeast and mammalian pre-mRNA splicing systems has advanced our understanding of the roles of protein factors in the early steps of spliceosome assembly. New results on the stereochemistry of nuclear pre-mRNA splicing and data on the transposition of Group II self-splicing introns in vivo have fuelled the long-running debate on the evolution of introns and RNA splicing.
Asunto(s)
Empalme Alternativo , Precursores del ARN/metabolismo , ARN Mensajero/metabolismo , Animales , Catálisis , Humanos , Intrones , Fosfoproteínas/genética , Fosfoproteínas/metabolismo , Empalmosomas/metabolismoRESUMEN
Therapeutic efficacy for depression and panic disorder has been demonstrated with the triazolobenzodiazepine alprazolam. However, potentially serious adverse events, including depression and suicide attempts, have been reported in patients taking this medication. In this paper, reports addressing the association between each of these two events and benzodiazepine use in general and, more specifically, alprazolam use, are reviewed. We conclude that while these adverse events do occur in patients taking alprazolam, the causal relationship remains unclear and requires further study. Fortunately, these events are observed only rarely, so the prudent clinician may continue to safely prescribe this useful medication.
Asunto(s)
Alprazolam/efectos adversos , Trastorno Depresivo/inducido químicamente , Intento de Suicidio/estadística & datos numéricos , Suicidio/psicología , Adolescente , Adulto , Anciano , Alprazolam/uso terapéutico , Benzodiazepinas/efectos adversos , Benzodiazepinas/uso terapéutico , Ensayos Clínicos como Asunto , Trastorno Depresivo/tratamiento farmacológico , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Multicéntricos como Asunto , Trastorno de Pánico/tratamiento farmacológicoRESUMEN
Intravenous administration of human basic fibroblast growth factor up to 100 micrograms/kg/day to Sprague-Dawley rats caused changes in the kidneys that included enlargement, vacuolation, and karyomegaly of podocytes in glomeruli, dilatation and cast formation in tubules, thickening of the media in the lobular arteries, and hyperplasia of the epithelium of the papilla and collecting ducts. In cynomolgus monkeys there was hyperplasia of the parietal epithelium of Bowman's capsule in the glomeruli, tubular dilatation, and minimal arteriopathy. These changes were only seen at 100 micrograms/kg/day. The development and eventual recovery over time were investigated in a sequence of sacrifices. In monkeys the first changes were seen after 7 days of treatment, but in rats only after 16 days. In both species the changes had partially resolved after 30 days of recovery and were considered to return to normal after 60 days without treatment. The morphological changes were accompanied by functional alterations that included proteinuria and raised blood urea. Changes that occurred in other tissues including bone, red blood cells, adrenals, ovaries, liver, gall bladder, spleen, mesenteric lymph nodes, thymus, aorta, salivary glands, and injection site are not described in this paper.